Marshall Wace
CGEN icon

Marshall Wace’s Compugen CGEN Stock Holding History

Marshall Wace’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Sell
19,617
-224,863
-92% -$564K ﹤0.01% 2999
2026
Q1 		$521K Buy
244,480
+138,176
+130% +$268K ﹤0.01% 2431
2025
Q4 		$163K Buy
106,304
+61,202
+136% +$102K ﹤0.01% 2635
2025
Q3 		$66.3K Buy
+45,102
New +$67K ﹤0.01% 2700
2025
Q2 		– Sell
-40,489
Closed -$59.1K – 2748
2025
Q1 		$59.1K Sell
40,489
-47,680
-54% -$93.1K ﹤0.01% 2525
2024
Q4 		$135K Buy
88,169
+40,494
+85% +$65.8K ﹤0.01% 2411
2024
Q3 		$86.3K Buy
+47,675
New +$87K ﹤0.01% 2391
2022
Q3 		– Sell
-13,415
Closed -$25K – 3382
2022
Q2 		$25K Buy
+13,415
New +$29K ﹤0.01% 3354
2022
Q1 		– Sell
-561,335
Closed -$2.41M – 3406
2021
Q4 		$2.41M Buy
561,335
+544,853
+3,306% +$2.95M ﹤0.01% 1925
2021
Q3 		$100K Sell
16,482
-80,387
-83% -$538K ﹤0.01% 2890
2021
Q2 		$802K Buy
96,869
+56,484
+140% +$459K ﹤0.01% 1918
2021
Q1 		$339K Buy
+40,385
New +$448K ﹤0.01% 2087

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

Marshall Wace's CGEN Position: Q2 2026 in Review

Marshall Wace reduced its Compugen (CGEN) stake by 92% in Q2 2026, selling an estimated $564K and leaving 19,617 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

Marshall Wace first reported a position in CGEN in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.41M in Q4 2021. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Marshall Wace held 19,617 shares of Compugen worth $42K as of Q2 2026.
  • Marshall Wace sold 224,863 Compugen shares in Q2 2026, an estimated $564K.
  • Compugen made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2999 holding.
  • Marshall Wace first reported a position in Compugen in Q1 2021 and has held it in 12 quarters since.
  • Marshall Wace's Compugen position peaked at $2.41M in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.